Skip to main content
UniHealth

Doctor search

Richard T Frederick, MD

Gastroenterology · San Francisco

NPI 1720009160

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: California Pacific Medical Center- Van Ness Campus · Enloe Health · Mills-Peninsula Medical Center · Oroville Hospital · Sutter Lakeside Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Frederick’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A71441 · Current

Licensed to practise in California · since 2000 · expires 2028-04-30 · New York Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

5 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
  • Enloe HealthChico, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Enloe Medical CenterPatients rate it 3 of 5 · 73% would definitely recommend it
    Overall rating: 3 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.9 (5.5 to 8.6) · 730 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
  • Oroville HospitalOroville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of OroHealth CorporationPatients rate it 1 of 5 · 35% would definitely recommend it
    Overall rating: 1 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 16.04 (9.53 to 22.55) · 404 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (11.1 to 19.4) · 136 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.262, Oct 2024 – Sep 2025
  • Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
  • Sutter Lakeside HospitalLakeport, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend it
    Overall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at California Pacific Medical Center- Van Ness Campus
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.224BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.325BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.373BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.14 (0.3 to 1.97) · 2,271 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.81 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths192.86 (151.51 to 234.22) · 140 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths10.3 · 60 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.5 · 143 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.8 · 356 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.3 · 259 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 173 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,316 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.31 (0.12 to 0.49) · 6,430 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.09 to 0.47) · 7,168 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.3 (1.5 to 5.09) · 2,196 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.47 (1.21 to 3.74) · 925 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.63 (1.37 to 3.88) · 1,954 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.13 (6.06 to 14.2) · 1,112 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.26 (4.67 to 9.85) · 1,084 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.67 (0.31 to 3.03) · 832 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.33 (0 to 0.85) · 5,406 casesNo differentJul 2022 – Jun 2024
MRSA BacteremiaInfections0.443No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.717No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 200 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.3 · 449 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits18.2 · 187 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits8.7 · 418 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits7.1 · 260 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19.2 · 293 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (3.6 to 7.6) · 157 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.2 (7.7 to 13.5) · 157 casesNo differentJan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits11 · 33 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 66 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.5 (9.4 to 16.7) · 551 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.3) · 219 casesNo differentJan 2024 – Dec 2024

What patients said (478 patients answered, 20% of those asked)

Patient survey stars by topic at California Pacific Medical Center- Van Ness Campus
Cleanliness4
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at California Pacific Medical Center- Van Ness Campus
Room was "always" clean75%
Nurses "always" communicated well74%
Doctors "always" communicated well77%
Staff "always" explained59%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand70%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Enloe Health

Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Enloe Health
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.9 (5.5 to 8.6) · 730 casesWorseJan 2024 – Dec 2024
Clostridium Difficile (C.Diff)Infections0.185BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.79 (0.96 to 2.62) · 2,849 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.99 (0.74 to 1.24)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths203.04 (164.55 to 241.54) · 191 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.8 · 117 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths9.8 · 377 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.4 · 377 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.2 · 1,088 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths16.2 · 1,160 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.2 · 375 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 4,102 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.05 to 0.39) · 14,875 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.17 (0 to 0.34) · 15,303 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.75 (2.11 to 5.39) · 3,517 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2.14 (0.71 to 3.56) · 1,262 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.89 (1.62 to 4.17) · 3,062 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.91 (1.48 to 12.34) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.79 (1.66 to 7.91) · 1,219 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.04 (0.64 to 3.43) · 643 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.71 (0.24 to 1.18) · 11,884 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.3 · 150 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.739No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.481No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.381No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.344No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.1 · 328 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.7 · 1,020 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-4.9 · 400 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits9.3 · 1,292 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits13.3 · 1,204 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 1,055 casesNoneJul 2023 – Jun 2025
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.4 (10.4 to 14.7) · 730 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 102 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 90 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 304 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.9 (12.1 to 18.1) · 3,626 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 1,340 casesNo differentJan 2024 – Dec 2024

What patients said (1,476 patients answered, 21% of those asked)

Patient survey stars by topic at Enloe Health
Cleanliness2
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Enloe Health
Room was "always" clean57%
Nurses "always" communicated well79%
Doctors "always" communicated well77%
Staff "always" explained59%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand70%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)69%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night40%
"YES", patients would definitely recommend the hospital73%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms87%
See every measure and the patient survey for Oroville Hospital

Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 4 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Oroville Hospital
Postoperative respiratory failure rateComplications and deaths16.04 (9.53 to 22.55) · 404 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.7 (11.1 to 19.4) · 136 casesWorseJan 2024 – Dec 2024
Clostridium Difficile (C.Diff)Infections0.262BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.07 (0.1 to 2.04) · 1,061 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.94 (0.64 to 1.23)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths161.51 (102.1 to 220.92) · 64 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths5.3 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.6 · 69 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.6 · 205 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths12.8 · 749 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths19.1 · 141 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.8 · 1,984 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.14 (0 to 0.33) · 7,583 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.31 (0.12 to 0.5) · 7,702 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.75 (0.69 to 4.81) · 1,113 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.44 (0 to 3.05) · 384 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.71 (0.23 to 3.2) · 1,061 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.47 (1.06 to 7.88) · 340 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.07) · 214 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.11 (0 to 0.69) · 4,910 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 161 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.497No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.451No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.1 · 39 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits26.7 · 239 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-24 · 54 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits66.7 · 254 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits60.8 · 898 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits25.5 · 851 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.4 (2.9 to 6.6) · 136 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits7.8 · 176 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits22.8 · 96 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14 (10.8 to 17.9) · 1,050 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.5) · 285 casesNo differentJan 2024 – Dec 2024

What patients said (769 patients answered, 12% of those asked)

Patient survey stars by topic at Oroville Hospital
Cleanliness1
Nurse communication1
Doctor communication2
Communication about medicines1
Discharge information1
Overall hospital rating1
Quietness1
Recommend hospital1
Share of patients giving the best answer at Oroville Hospital
Room was "always" clean43%
Nurses "always" communicated well64%
Doctors "always" communicated well66%
Staff "always" explained45%
Yes, staff "did" give patients this information77%
Yes, staff "did" give patients information about help after discharge74%
Doctors "always" explained things so they could understand60%
Doctors "always" listened carefully63%
Doctors "always" treated them with courtesy and respect75%
Patients who gave a rating of "9" or "10" (high)35%
Staff "always" explained new medications57%
Nurses "always" explained things so they could understand59%
Nurses "always" listened carefully60%
Nurses "always" treated them with courtesy and respect73%
"Always" quiet at night29%
"YES", patients would definitely recommend the hospital35%
Staff "always" explained possible side effects33%
Yes, staff "did" give patients information about possible symptoms80%
See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Peninsula Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.139BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.242BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.27 to 2.15) · 1,258 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.51 to 1.1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths155.44 (112.67 to 198.21) · 90 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 188 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9 · 473 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 342 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 485 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 3,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 6,904 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,052 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.43 to 5.39) · 1,695 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.72 (0.17 to 3.28) · 665 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,545 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.1 (1.3 to 12.9) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.96 (2.63 to 9.29) · 653 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.08) · 418 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.14 (0 to 0.78) · 5,539 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.7 · 192 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.215No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.263No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.74No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 300 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.2 · 207 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.6 · 531 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits24.3 · 343 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 449 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.5 (2.8 to 7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.6 (6.7 to 13.7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11 · 45 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 117 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.2) · 584 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 764 casesNo differentJan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Patient survey stars by topic at Peninsula Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean76%
Nurses "always" communicated well81%
Doctors "always" communicated well80%
Staff "always" explained58%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Sutter Lakeside Hospital

Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Sutter Lakeside Hospital
Death rate for COPD patientsComplications and deaths8.7 · 46 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.7 · 94 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.2 · 133 casesNoneJul 2022 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.9 · 379 casesNoneJul 2024 – Jun 2025
Rate of complications for hip/knee replacement patientsComplications and deaths3.8 · 31 casesNoneApr 2023 – Mar 2025
Clostridium Difficile (C.Diff)Infections1.249No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.9 · 72 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-25.4 · 92 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-37.9 · 137 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.3 · 109 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 36 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 47 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.2 (9.9 to 17.3) · 564 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.6 to 1.3) · 52 casesNo differentJan 2024 – Dec 2024

What patients said (209 patients answered, 18% of those asked)

Patient survey stars by topic at Sutter Lakeside Hospital
Cleanliness5
Nurse communication4
Doctor communication4
Communication about medicines4
Discharge information4
Overall hospital rating4
Quietness4
Recommend hospital4
Share of patients giving the best answer at Sutter Lakeside Hospital
Room was "always" clean83%
Nurses "always" communicated well79%
Doctors "always" communicated well79%
Staff "always" explained70%
Yes, staff "did" give patients this information90%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications82%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night63%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects58%
Yes, staff "did" give patients information about possible symptoms91%

Original Medicare doctor bills

$123,191

Medicare paid this office $123,191 for 461 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes65$30,246$104
Long return visit (40+ min)145$28,986$120
Long return visit (40+ min)148$27,315$128
Initial hospital care with moderate level of medical decision making at least 75 minutes42$7,355$153
New patient visit (60+ min)39$6,669$171
See all 11 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes65$30,246$104
Long return visit (40+ min)145$28,986$120
Long return visit (40+ min)148$27,315$128
Initial hospital care with moderate level of medical decision making at least 75 minutes42$7,355$153
New patient visit (60+ min)39$6,669$171
Critical care, first 30-74 minutes15$4,610$184
Return visit (30+ min)35$3,471$89
Return visit (30+ min)35$2,828$76
New patient visit (45+ min)16$1,839$115
New patient visit (60+ min)13$1,808$139
Measurement of liver stiffness29$735$25

Procedures Medicare counted

Procedure volume Medicare published
Colonoscopy1-10None
Upper gastrointestinal (GI) endoscopy for acid reflux23More than 52% of doctors who do this

Who their Medicare patients are

461 Original Medicare patients in 2024. Average age 69 · Under 65 19% · 85 and older 3% · Women 50% · Also on Medicaid 39% · Health risk score 2.36. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.

Conditions among them: High blood pressure 74% · Diabetes 39% · Chronic kidney disease 36% · Depression 25% · Coronary heart disease 23% · Heart failure 19% · COPD 17% · Atrial fibrillation 17% · Cancer 13% · Dementia 6% · Stroke 6%.

The office billed $546,964, Medicare allowed $164,391 and paid $123,191; for 1,066 services of 22 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244611,066692.36$546,964$123,191
20234501,001682.43$504,427$116,359
20224671,030682.26$510,321$119,442
20214611,093682.41$513,673$126,731
20204791,175672.59$575,020$119,140
20194951,091672.62$551,856$104,104
20184601,030662.60$529,075$97,908
20174681,038662.38$523,821$96,379
20164871,100652.49$527,207$105,412
2015454970642.32$520,523$97,204
20144541,065642.26$600,585$121,724
20134611,077632.74$558,048$115,000

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Long return visit (40+ min)147$26,155$135
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes63$25,690$108
Long return visit (40+ min)120$21,848$118
Critical care, first 30-74 minutes13$10,610$189
Initial hospital care with moderate level of medical decision making at least 75 minutes39$6,766$157
New patient visit (60+ min)37$5,634$152
Return visit (30+ min)51$4,690$84
Return visit (30+ min)41$3,272$70
New patient visit (45+ min)15$1,759$117
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes14$1,651$72
Measurement of liver stiffness26$520$20

2022: 12 services

Original Medicare services billed in 2022
Long return visit (40+ min)131$28,944$123
Long return visit (40+ min)145$26,928$131
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes59$17,136$92
Critical care, first 30-74 minutes22$11,945$187
New patient visit (60+ min)47$7,624$162
Initial hospital care with moderate level of medical decision making at least 75 minutes35$6,555$172
Return visit (30+ min)48$4,283$75
Return visit (30+ min)47$4,252$89
New patient visit (60+ min)13$1,986$153
New patient visit (45+ min)16$1,517$95
Short return visit (20+ min)12$726$60
Measurement of liver stiffness26$653$24

2021: 14 services

Original Medicare services billed in 2021
Long return visit (40+ min)167$33,463$134
Long return visit (40+ min)134$27,033$120
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes66$21,345$93
Critical care, first 30-74 minutes16$9,770$195
Initial hospital care with moderate level of medical decision making at least 75 minutes37$6,878$181
New patient visit (60+ min)39$6,289$161
Return visit (30+ min)45$5,045$93
Return visit (30+ min)46$4,166$80
New patient visit (60+ min)12$2,060$172
New patient visit (45+ min)15$1,648$110
Telephone medical discussion with physician, 21-30 minutes18$1,465$81
Telephone medical discussion with physician, 21-30 minutes11$834$76
Measurement of liver stiffness15$154$10
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito14$72$5

2020: 15 services

Original Medicare services billed in 2020
Long return visit (40+ min)152$24,418$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes67$24,251$94
Long return visit (40+ min)118$17,146$92
Critical care, first 30-74 minutes12$12,129$199
Initial hospital care with moderate level of medical decision making at least 75 minutes42$7,672$183
New patient visit (60+ min)39$5,806$149
Telephone medical discussion with physician, 21-30 minutes53$5,634$89
Return visit (30+ min)56$4,914$81
Return visit (30+ min)46$2,856$57
New patient visit (60+ min)20$2,511$126
Telephone medical discussion with physician, 21-30 minutes20$1,601$73
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes13$1,513$66
New patient visit (45+ min)11$1,048$95
Measurement of liver stiffness26$303$11
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito16$84$5

2019: 17 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes78$25,958$94
Long return visit (40+ min)127$18,406$105
Long return visit (40+ min)77$10,171$92
Initial hospital care with moderate level of medical decision making at least 75 minutes47$9,020$180
Return visit (30+ min)73$5,236$61
Return visit (30+ min)58$4,714$77
New patient visit (60+ min)30$4,323$144
New patient visit (60+ min)24$3,398$142
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes23$2,230$66
New patient visit (45+ min)17$2,070$122
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope19$1,885$99
New patient visit (45+ min)15$1,505$100
Short return visit (20+ min)16$784$39
Short return visit (20+ min)11$678$57
Measurement of liver stiffness42$561$12
Measurement of liver stiffness19$531$28
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito19$97$5

2018: 14 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes74$23,007$90
Long return visit (40+ min)155$22,082$105
Critical care, first 30-74 minutes22$10,170$188
Long return visit (40+ min)76$9,700$90
Initial hospital care with moderate level of medical decision making at least 75 minutes40$7,159$175
Return visit (30+ min)55$4,545$73
Return visit (30+ min)60$3,918$58
New patient visit (60+ min)20$2,799$140
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$2,399$62
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope16$1,533$96
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope13$1,417$109
Measurement of liver stiffness32$444$12
Measurement of liver stiffness12$321$27
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito23$116$5

2017: 17 services

Original Medicare services billed in 2017
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes62$18,796$90
Long return visit (40+ min)133$18,560$105
Long return visit (40+ min)87$12,258$88
Initial hospital care with moderate level of medical decision making at least 75 minutes39$7,066$172
Critical care, first 30-74 minutes12$6,457$190
Return visit (30+ min)72$6,027$75
Return visit (30+ min)71$5,031$61
New patient visit (60+ min)27$4,255$158
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope23$2,430$106
New patient visit (60+ min)16$2,329$146
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$2,131$63
New patient visit (45+ min)14$1,623$116
New patient visit (45+ min)12$1,226$102
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope12$1,090$91
Measurement of liver stiffness38$485$12
Measurement of liver stiffness14$315$22
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito27$149$5

2016: 12 services

Original Medicare services billed in 2016
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes73$27,758$93
Long return visit (40+ min)168$24,315$106
Long return visit (40+ min)86$12,823$91
Initial hospital care with moderate level of medical decision making at least 75 minutes36$6,886$181
Return visit (30+ min)65$5,148$63
Return visit (30+ min)54$4,889$79
New patient visit (60+ min)31$4,803$155
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$2,394$65
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope17$2,014$118
New patient visit (60+ min)14$1,936$138
Measurement of liver stiffness22$581$26
Measurement of liver stiffness45$544$12

2015: 11 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes74$21,334$93
Long return visit (40+ min)158$20,289$103
Long return visit (40+ min)76$9,902$93
Initial hospital care with moderate level of medical decision making at least 75 minutes41$7,752$180
New patient visit (60+ min)37$5,962$161
Return visit (30+ min)57$4,046$66
Return visit (30+ min)61$3,920$63
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes32$3,485$65
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope26$3,001$115
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope17$1,996$111
Measurement of liver stiffness30$390$13

2014: 12 services

Original Medicare services billed in 2014
Long return visit (40+ min)192$41,559$116
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes67$17,543$93
Return visit (30+ min)109$11,223$83
Critical care, first 30-74 minutes11$9,215$196
Initial hospital care with moderate level of medical decision making at least 75 minutes43$8,130$181
New patient visit (60+ min)43$7,378$172
Long return visit (40+ min)36$4,751$95
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope33$3,788$115
New patient visit (45+ min)30$3,681$123
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$3,345$64
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes20$2,567$122
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope12$1,243$89

2013: 10 services

Original Medicare services billed in 2013
Long return visit (40+ min)249$41,796$111
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes76$24,151$90
Return visit (30+ min)88$8,912$87
Initial hospital care with moderate level of medical decision making at least 75 minutes46$8,458$176
New patient visit (60+ min)49$7,930$162
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes45$5,375$63
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope20$2,543$121
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,264$119
New patient visit (45+ min)14$1,950$139
Long return visit (40+ min)11$1,084$83

Medicaid work

$22,430 in 2024

Medicaid paid $22,430 for 364 billed services this clinician did in 2024, up to 32 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)232$14,545
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES132$7,885
Medicaid work by year
2024364232$22,430
2023414232$28,285
2022334229$20,033
2021382237$26,781
2020327235$16,926
2019135225$8,481
2018175218$10,883
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)303$21,200
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES111$7,086

2022

Largest Medicaid services in 2022
Long return visit (40+ min)236$15,042
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES98$4,991

2021

Largest Medicaid services in 2021
Long return visit (40+ min)300$22,785
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES82$3,996

2020

Largest Medicaid services in 2020
Long return visit (40+ min)284$15,355
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES43$1,571

2019

Largest Medicaid services in 2019
Long return visit (40+ min)100$6,693
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES35$1,788

2018

Largest Medicaid services in 2018
Long return visit (40+ min)95$6,816
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES80$4,067

Drugs they prescribed that Part D paid

$1,729,606

Pharmacies billed $1,729,606 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

1,409 generic and fewer than 11 brand-name prescriptions · $1,729,606 in drug cost · 205 antibiotic prescriptions to 34 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Epclusa18$422,141$23,452
Xifaxan122$402,504$3,299
Vemlidy151$238,599$1,580
Rezdiffra24$90,651$3,777
Entecavir120$47,114$393
See all 30 drugs
Every Part D drug this clinician prescribed
Epclusa18$422,141$23,452
Xifaxan122$402,504$3,299
Vemlidy151$238,599$1,580
Rezdiffra24$90,651$3,777
Entecavir120$47,114$393
Ursodiol241$40,011$166
Tacrolimus248$29,616$119
Mycophenolate Mofetil62$11,912$192
Eliquis17$10,198$600
Prograf19$10,163$535
Mycophenolic Acid27$5,047$187
Lactulose72$4,029$56
Valganciclovir22$3,602$164
Budesonide Ec21$3,425$163
Budesonide Dr15$2,255$150
Pantoprazole65$810$12
Spironolactone54$759$14
Eplerenone27$755$28
Constulose15$705$47
Prednisone65$684$11
Furosemide69$553$8
Fenofibrate16$534$33
Azathioprine13$417$32
Fluconazole20$346$17
Sulfamethoxazole-Trimethoprim52$247$5
Omeprazole22$198$9
Amoxicillin-Clavulanate Potass11$102$9
Amlodipine Besylate13$49$4
Metoprolol17$40$2
Carvedilol20$23$1

Year by year

Part D prescribing by year
20241,898242NoneNone$1,729,606
20231,605231NoneNone$1,334,969
20221,765223NoneNone$2,115,235
20211,618210NoneNone$1,387,425
20201,767200NoneNone$2,169,024
20191,528201None33%$1,453,573
20181,4761881% (12)27%$1,307,338
20171,4981851% (19)31%$1,988,973
20161,4221781% (18)None$2,426,921
20151,9042271% (20)None$8,385,128
20141,8342141% (24)38%$5,771,629
20131,6792082% (32)38%$736,265

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 23 drugs

Part D drugs prescribed in 2023
Xifaxan109$394,140$3,616
Vemlidy136$247,240$1,818
Entecavir109$51,471$472
Ursodiol225$48,287$215
Tacrolimus224$47,044$210
Mycophenolate Mofetil58$15,176$262
Budesonide Dr35$12,260$350
Prograf11$10,611$965
Lactulose90$6,409$71
Budesonide Ec13$3,602$277
Spironolactone60$1,305$22
Constulose14$1,192$85
Prednisone60$1,032$17
Bumetanide12$966$80
Eplerenone14$937$67
Azathioprine27$820$30
Furosemide63$628$10
Pantoprazole40$578$14
Metoprolol18$299$17
Omeprazole15$178$12
Sulfasalazine11$173$16
Sulfamethoxazole-Trimethoprim13$51$4
Carvedilol14$44$3

2022: 26 drugs

Part D drugs prescribed in 2022
Epclusa35$932,265$26,636
Xifaxan138$458,211$3,320
Vemlidy141$209,374$1,485
Ocaliva18$170,825$9,490
Ursodiol247$67,586$274
Tacrolimus208$33,997$163
Entecavir86$23,766$276
Valganciclovir11$18,365$1,670
Lactulose95$7,308$77
Mycophenolate Mofetil66$7,047$107
Budesonide Ec27$6,783$251
Budesonide Dr32$6,183$193
Mycophenolic Acid14$5,748$411
Spironolactone80$1,410$18
Constulose17$1,192$70
Azathioprine17$1,188$70
Eplerenone14$1,157$83
Prednisone63$800$13
Pantoprazole64$754$12
Cyclosporine Modified17$730$43
Furosemide102$561$6
Midodrine11$521$47
Fluconazole12$446$37
Sulfasalazine11$231$21
Sulfamethoxazole-Trimethoprim22$97$4
Omeprazole11$72$7

2021: 22 drugs

Part D drugs prescribed in 2021
Xifaxan174$498,853$2,867
Epclusa14$366,655$26,190
Vemlidy99$147,813$1,493
Ursodiol217$57,834$267
Tacrolimus181$35,020$193
Entecavir80$19,237$240
Mycophenolic Acid12$7,945$662
Valganciclovir20$7,639$382
Mycophenolate Mofetil47$6,956$148
Lactulose105$5,952$57
Budesonide Ec22$3,459$157
Budesonide Dr20$2,704$135
Spironolactone92$2,177$24
Azathioprine31$1,467$47
Cyclosporine Modified17$1,238$73
Pantoprazole81$745$9
Constulose15$646$43
Prednisone43$482$11
Fluconazole11$472$43
Furosemide67$465$7
Omeprazole23$248$11
Sulfamethoxazole-Trimethoprim14$64$5

2020: 25 drugs

Part D drugs prescribed in 2020
Epclusa34$874,389$25,717
Xifaxan210$566,120$2,696
Vemlidy77$127,772$1,659
Ursodiol224$81,003$362
Truvada12$38,160$3,180
Tacrolimus174$34,941$201
Entecavir78$22,145$284
Valganciclovir30$15,221$507
Budesonide Ec47$13,804$294
Mycophenolic Acid14$8,600$614
Mycophenolate Mofetil73$8,123$111
Lactulose93$5,889$63
Spironolactone109$2,117$19
Cyclosporine Modified22$1,993$91
Azathioprine28$1,447$52
Ribavirin15$1,037$69
Constulose28$958$34
Pantoprazole78$724$9
Fluconazole14$667$48
Furosemide89$571$6
Prednisone32$478$15
Levothyroxine21$259$12
Omeprazole19$241$13
Sulfamethoxazole-Trimethoprim20$90$5
Metoprolol14$85$6

2019: 27 drugs

Part D drugs prescribed in 2019
Xifaxan158$382,967$2,424
Mavyret12$158,804$13,234
Vemlidy98$134,011$1,367
Ursodiol186$79,654$428
Ocaliva11$75,415$6,856
Entecavir86$34,764$404
Truvada17$31,159$1,833
Tacrolimus208$18,219$88
Budesonide Ec57$11,138$195
Mycophenolate Mofetil54$9,528$176
Mycophenolic Acid22$4,236$193
Levemir11$3,421$311
Tenofovir Disoproxil17$3,261$192
Lactulose64$2,903$45
Azathioprine38$2,170$57
Spironolactone66$1,531$23
Eplerenone12$1,467$122
Cyclosporine Modified21$1,350$64
Furosemide60$551$9
Pantoprazole42$523$12
Metolazone13$509$39
Constulose20$378$19
Levothyroxine24$312$13
Prednisone26$197$8
Ciprofloxacin17$181$11
Omeprazole12$129$11
Metoprolol11$95$9

2018: 24 drugs

Part D drugs prescribed in 2018
Xifaxan143$314,119$2,197
Ursodiol147$87,149$593
Entecavir110$74,488$677
Vemlidy49$65,306$1,333
Truvada12$21,376$1,781
Tenofovir Disoproxil39$17,888$459
Tacrolimus165$17,458$106
Viread12$14,416$1,201
Budesonide Ec55$13,645$248
Mycophenolate Mofetil46$6,207$135
Mycophenolic Acid21$5,130$244
Eplerenone13$2,484$191
Lactulose73$2,421$33
Azathioprine37$1,935$52
Spironolactone103$1,246$12
Furosemide102$508$5
Prednisone29$406$14
Pantoprazole33$378$11
Fludrocortisone Acetate13$234$18
Amlodipine Besylate21$182$9
Levothyroxine13$166$13
Ciprofloxacin14$75$5
Metoprolol19$71$4
Sulfamethoxazole-Trimethoprim17$61$4

2017: 26 drugs

Part D drugs prescribed in 2017
Harvoni13$416,144$32,011
Epclusa11$266,863$24,260
Xifaxan108$248,112$2,297
Entecavir114$96,633$848
Viread66$72,803$1,103
Ursodiol121$53,081$439
Budesonide Ec56$36,223$647
Tacrolimus165$16,311$99
Mycophenolic Acid27$12,718$471
Mycophenolate Mofetil53$11,405$215
Lactulose48$2,316$48
Amiloride14$2,136$153
Azathioprine45$1,871$42
Spironolactone83$993$12
Nystatin16$528$33
Prednisone42$456$11
Furosemide84$353$4
Pantoprazole34$349$10
Fludrocortisone Acetate16$274$17
Omeprazole24$242$10
Amlodipine Besylate22$209$10
Ciprofloxacin21$193$9
Ondansetron13$92$7
Hydroxyzine11$65$6
Sulfamethoxazole-Trimethoprim22$42$2
Metoprolol14$42$3

2016: 29 drugs

Part D drugs prescribed in 2016
Harvoni29$912,426$31,463
Sovaldi13$351,000$27,000
Epclusa14$333,546$23,825
Xifaxan87$172,671$1,985
Entecavir107$76,471$715
Viread61$58,746$963
Ursodiol105$56,965$543
Budesonide Ec54$26,168$485
Valganciclovir15$22,983$1,532
Truvada12$19,294$1,608
Mycophenolic Acid25$13,128$525
Cellcept12$11,229$936
Tacrolimus137$10,318$75
Mycophenolate Mofetil75$8,479$113
Ribavirin27$3,952$146
Amiloride27$2,876$107
Azathioprine43$1,653$38
Lactulose42$1,636$39
Nadolol24$1,517$63
Spironolactone61$995$16
Prednisone53$919$17
Pantoprazole45$348$8
Furosemide58$328$6
Omeprazole24$261$11
Levothyroxine13$132$10
Amlodipine Besylate32$100$3
Metoprolol12$64$5
Tramadol12$60$5
Sulfamethoxazole-Trimethoprim13$49$4

2015: 34 drugs

Part D drugs prescribed in 2015
Harvoni216$6,794,508$31,456
Sovaldi30$801,042$26,701
Xifaxan86$138,275$1,608
Viread97$94,437$974
Entecavir95$91,690$965
Ursodiol81$52,003$642
Ribavirin130$25,269$194
Tacrolimus133$21,159$159
Budesonide Ec46$18,224$396
Sirolimus13$9,852$758
Prograf13$6,440$495
Truvada14$5,532$395
Mycophenolate Mofetil52$5,018$96
Cyclosporine Modified16$3,427$214
Lactulose34$3,122$92
Nadolol27$2,512$93
Spironolactone71$1,307$18
Amiloride11$1,020$93
Pantoprazole83$729$9
Prednisone28$623$22
Omeprazole54$616$11
Nystatin12$430$36
Furosemide67$404$6
Azathioprine13$357$27
Amlodipine Besylate61$317$5
Zolpidem19$311$16
Metoprolol46$288$6
Fludrocortisone Acetate11$215$20
Levothyroxine13$158$12
Metronidazole16$130$8
Sulfamethoxazole-Trimethoprim19$118$6
Ciprofloxacin19$110$6
Hydrocodone-Acetaminophen14$84$6
Trazodone11$83$8

2014: 38 drugs

Part D drugs prescribed in 2014
Sovaldi95$2,702,594$28,448
Harvoni43$1,374,633$31,968
Olysio45$1,018,420$22,632
Xifaxan122$176,151$1,444
Viread94$92,693$986
Valcyte23$90,260$3,924
Baraclude60$71,521$1,192
Entecavir31$29,678$957
Ursodiol63$20,007$318
Tacrolimus88$17,095$194
Budesonide Ec15$9,377$625
Ribavirin52$9,363$180
Kristalose13$9,161$705
Rapamune13$6,779$521
Dyrenium13$5,864$451
Mycophenolate Mofetil53$5,717$108
Nexium12$4,629$386
Nadolol45$4,288$95
Humalog11$3,974$361
Cyclosporine24$3,791$158
Spironolactone85$2,382$28
Lactulose38$2,321$61
Prograf12$2,142$179
Generlac17$1,438$85
Pantoprazole84$1,391$17
Prednisone38$880$23
Omeprazole50$782$16
Amlodipine Besylate59$476$8
Furosemide78$445$6
Metoprolol67$390$6
Fludrocortisone Acetate17$268$16
Olanzapine11$267$24
Azathioprine11$267$24
Levothyroxine15$202$13
Propranolol23$180$8
Sulfamethoxazole-Trimethoprim41$177$4
Trazodone18$150$8
Tramadol12$59$5

2013: 36 drugs

Part D drugs prescribed in 2013
Xifaxan112$159,031$1,420
Viread112$107,932$964
Valcyte29$104,524$3,604
Baraclude79$80,465$1,019
Pegasys20$57,638$2,882
Tacrolimus72$19,844$276
Neupogen13$18,784$1,445
Myfortic22$11,664$530
Budesonide Ec15$9,239$616
Prograf32$9,073$284
Ursodiol67$8,495$127
Mycophenolate Mofetil77$8,429$109
Rapamune22$8,317$378
Kristalose16$3,559$222
Nadolol52$3,284$63
Spironolactone68$2,992$44
Protonix12$2,830$236
Cyclosporine16$2,574$161
Gengraf15$1,898$127
Lactulose34$1,854$55
Amiloride15$1,326$88
Pantoprazole65$958$15
Omeprazole50$903$18
Prednisone47$531$11
Amlodipine Besylate45$443$10
Furosemide64$411$6
Fludrocortisone Acetate29$388$13
Olanzapine13$319$25
Azathioprine21$259$12
Metoprolol48$215$4
Hydrocodone-Acetaminophen14$208$15
Propranolol19$181$10
Ciprofloxacin17$144$8
Trazodone17$138$8
Sulfamethoxazole-Trimethoprim32$116$4
Levothyroxine11$103$9

Money from drug and device companies

$45,689 in 2025

Industry payments by year
2025735$42,547$45,689
2024315$18,548$21,359
202322$5,893$5,893
202224$5,005$5,211
202117$20,770$20,770
2020210$31,458$32,103
2019411$10,920$11,420

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Madrigal PharmaceuticalsRezdiffra$41,813
27 payments
  • Meals for Rezdiffra · 2025-10-29 · $139
  • Paid to speak or teach for Rezdiffra · 2025-10-29 · $3,878
  • Travel for Rezdiffra · 2025-10-29 · $141
  • Meals for Rezdiffra · 2025-09-11 · $95
  • Paid to speak or teach for Rezdiffra · 2025-09-11 · $3,878
  • Travel for Rezdiffra · 2025-09-11 · $131
  • Meals for Rezdiffra · 2025-08-18 · $142
  • Paid to speak or teach for Rezdiffra · 2025-08-18 · $4,935
  • Travel for Rezdiffra · 2025-08-18 · $17
  • Meals for Rezdiffra · 2025-08-12 · $73
  • Paid to speak or teach for Rezdiffra · 2025-08-12 · $3,878
  • Travel for Rezdiffra · 2025-08-12 · $122
  • Paid to speak or teach for Rezdiffra · 2025-07-31 · $1,234
  • Meals for Rezdiffra · 2025-07-30 · $104
  • Paid to speak or teach for Rezdiffra · 2025-07-30 · $3,878
  • Travel for Rezdiffra · 2025-07-30 · $185
  • Paid to speak or teach for Rezdiffra · 2025-06-26 · $3,878
  • Meals for Rezdiffra · 2025-06-26 · $137
  • Travel for Rezdiffra · 2025-06-26 · $116
  • Paid to speak or teach for Rezdiffra · 2025-04-14 · $4,935
  • Meals for Rezdiffra · 2025-04-14 · $55
  • Paid to speak or teach for Rezdiffra · 2025-03-10 · $3,878
  • Meals for Rezdiffra · 2025-02-11 · $108
  • Paid to speak or teach for Rezdiffra · 2025-02-11 · $4,935
  • Travel for Rezdiffra · 2025-02-11 · $810
  • Meals for Rezdiffra · 2025-01-29 · $33
  • Travel for Rezdiffra · 2025-01-29 · $99
Mallinckrodt Hospital ProductsTerlivaz$2,995
3 payments
  • Meals for Terlivaz · 2025-11-08 · $125
  • Consulting for Terlivaz · 2025-10-29 · $2,790
  • Meals for Terlivaz · 2025-05-07 · $80
Cipla USANone$450
1 payment
  • Consulting · 2025-02-10 · $450
Gilead SciencesLivdelzi$140
1 payment
  • Meals for Livdelzi · 2025-05-05 · $140
Salix Pharmaceuticals a division of Bausch Health USXifaxan$119
1 payment
  • Meals for Xifaxan · 2025-12-03 · $119
Cook MedicalEchotip Insight$112
1 payment
  • Meals for Echotip Insight · 2025-07-17 · $112
See all 35 published payments
Every published payment
Salix Pharmaceuticals a division of Bausch Health USMeals · 2025-12-03Xifaxan$119
Mallinckrodt Hospital ProductsMeals · 2025-11-08Terlivaz$125
Mallinckrodt Hospital ProductsConsulting · 2025-10-29Terlivaz$2,790
Madrigal PharmaceuticalsMeals · 2025-10-29Rezdiffra$139
Madrigal PharmaceuticalsPaid to speak or teach · 2025-10-29Rezdiffra$3,878
Madrigal PharmaceuticalsTravel · 2025-10-29Rezdiffra$141
Madrigal PharmaceuticalsMeals · 2025-09-11Rezdiffra$95
Madrigal PharmaceuticalsPaid to speak or teach · 2025-09-11Rezdiffra$3,878
Madrigal PharmaceuticalsTravel · 2025-09-11Rezdiffra$131
Madrigal PharmaceuticalsMeals · 2025-08-18Rezdiffra$142
Madrigal PharmaceuticalsPaid to speak or teach · 2025-08-18Rezdiffra$4,935
Madrigal PharmaceuticalsTravel · 2025-08-18Rezdiffra$17
Madrigal PharmaceuticalsMeals · 2025-08-12Rezdiffra$73
Madrigal PharmaceuticalsPaid to speak or teach · 2025-08-12Rezdiffra$3,878
Madrigal PharmaceuticalsTravel · 2025-08-12Rezdiffra$122
Madrigal PharmaceuticalsPaid to speak or teach · 2025-07-31Rezdiffra$1,234
Madrigal PharmaceuticalsMeals · 2025-07-30Rezdiffra$104
Madrigal PharmaceuticalsPaid to speak or teach · 2025-07-30Rezdiffra$3,878
Madrigal PharmaceuticalsTravel · 2025-07-30Rezdiffra$185
Cook MedicalMeals · 2025-07-17Echotip Insight$112
Madrigal PharmaceuticalsPaid to speak or teach · 2025-06-26Rezdiffra$3,878
Madrigal PharmaceuticalsMeals · 2025-06-26Rezdiffra$137
Madrigal PharmaceuticalsTravel · 2025-06-26Rezdiffra$116
Mallinckrodt Hospital ProductsMeals · 2025-05-07Terlivaz$80
Gilead SciencesMeals · 2025-05-05Livdelzi$140
Madrigal PharmaceuticalsPaid to speak or teach · 2025-04-14Rezdiffra$4,935
Madrigal PharmaceuticalsMeals · 2025-04-14Rezdiffra$55
Ipsen BiopharmaceuticalsMeals · 2025-03-18Iqirvo$62
Madrigal PharmaceuticalsPaid to speak or teach · 2025-03-10Rezdiffra$3,878
Madrigal PharmaceuticalsMeals · 2025-02-11Rezdiffra$108
Madrigal PharmaceuticalsPaid to speak or teach · 2025-02-11Rezdiffra$4,935
Madrigal PharmaceuticalsTravel · 2025-02-11Rezdiffra$810
Cipla USAConsulting · 2025-02-10None$450
Madrigal PharmaceuticalsMeals · 2025-01-29Rezdiffra$33
Madrigal PharmaceuticalsTravel · 2025-01-29Rezdiffra$99
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $21,359

Payments by company in 2024
Madrigal PharmaceuticalsRezdiffra$15,032
11 payments
  • Honoraria for Rezdiffra · 2024-12-17 · $7,050
  • Meals for Rezdiffra · 2024-12-06 · $50
  • Meals for Rezdiffra · 2024-12-06 · $58
  • Meals for Rezdiffra · 2024-12-06 · $74
  • Travel for Rezdiffra · 2024-12-05 · $1,324
  • Travel for Rezdiffra · 2024-12-05 · $845
  • Meals for Rezdiffra · 2024-12-05 · $45
  • Meals for Rezdiffra · 2024-12-05 · $211
  • Paid to speak or teach for Rezdiffra · 2024-12-03 · $3,878
  • Meals for Rezdiffra · 2024-12-03 · $88
  • Paid to speak or teach for Rezdiffra · 2024-11-19 · $1,410
Mallinckrodt Hospital ProductsTerlivaz$3,787
2 payments
  • Meals for Terlivaz · 2024-11-16 · $67
  • Consulting for Terlivaz · 2024-09-25 · $3,720
Ipsen BiopharmaceuticalsIqirvo$2,540
2 payments
  • Honoraria for Iqirvo · 2024-11-27 · $2,490
  • Meals for Iqirvo · 2024-11-18 · $50

2023: $5,893

Payments by company in 2023
Mallinckrodt Hospital ProductsTerlivaz$5,580
1 payment
  • Consulting for Terlivaz · 2023-12-20 · $5,580
TerSera TherapeuticsNone$313
1 payment
  • Consulting · 2023-07-15 · $313

2022: $5,211

Payments by company in 2022
Mallinckrodt Hospital ProductsTerlivaz$5,153
2 payments
  • Consulting for Terlivaz · 2022-12-07 · $5,005
  • Meals for Terlivaz · 2022-11-05 · $148
AstraZeneca UKNone$58
2 payments
  • Meals · 2022-05-11 · $14
  • Meals · 2022-05-11 · $44

2021: $20,770

Payments by company in 2021
Mallinckrodt Hospital ProductsNone$20,770
7 payments
  • Consulting · 2021-10-12 · $4,290
  • Consulting · 2021-08-25 · $2,860
  • Consulting · 2021-07-15 · $715
  • Consulting · 2021-04-28 · $3,575
  • Consulting · 2021-04-21 · $750
  • Consulting · 2021-03-30 · $3,575
  • Consulting · 2021-03-01 · $5,005

2020: $32,103

Payments by company in 2020
Mallinckrodt Hospital ProductsNone$27,558
6 payments
  • Consulting · 2020-12-07 · $3,150
  • Consulting · 2020-09-16 · $7,583
  • Consulting · 2020-08-22 · $4,550
  • Consulting · 2020-08-17 · $4,500
  • Consulting · 2020-07-10 · $2,250
  • Consulting · 2020-05-15 · $5,525
Intercept PharmaceuticalsNone$4,545
4 payments
  • Meals · 2020-03-04 · $40
  • Travel · 2020-03-04 · $605
  • Paid to speak or teach · 2020-03-04 · $3,400
  • Honoraria · 2020-02-21 · $500

2019: $11,420

Payments by company in 2019
Intercept PharmaceuticalsNone$7,193
3 payments
  • Meals · 2019-12-04 · $73
  • Paid to speak or teach · 2019-12-04 · $4,000
  • Honoraria · 2019-07-18 · $3,120
Mallinckrodt EnterprisesNone$3,698
5 payments
  • Meals · 2019-11-10 · $73
  • Consulting · 2019-07-09 · $3,350
  • Travel · 2019-07-09 · $176
  • Meals · 2019-05-22 · $63
  • Meals · 2019-05-22 · $36
Gilead SciencesNone$450
2 payments
  • Consulting · 2019-05-03 · $150
  • Consulting · 2019-03-01 · $300
Salix Pharmaceuticals a division of Bausch Health USXifaxan$79
1 payment
  • Meals for Xifaxan · 2019-06-17 · $79

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AstraZeneca Pharmaceuticals LP · A Two Part Phase Iia B Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study To Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and Dapagliflozin Monotherapy Versus Placebo in Participants With Cirrhosis With Features of Portal Hypertension · 2025Their institution$91,047
Mallinckrodt Enterprises LLC · A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study To Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 · 2019Their institution$66,664
Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2024Their institution$47,894
AstraZeneca Pharmaceuticals LP · A Two Part Phase Iia B Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study To Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and Dapagliflozin Monotherapy Versus Placebo in Participants With Cirrhosis With Features of Portal Hypertension · 2024Their institution$42,868
AstraZeneca Pharmaceuticals LP · A Two Part Phase Iia B Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study To Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and Dapagliflozin Monotherapy Versus Placebo in Participants With Cirrhosis With Features of Portal Hypertension · 2023Their institution$19,200
Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2025Their institution$15,838
Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2023Their institution$3,500

Professional record

NPI
1720009160
Licence
CA A71441California A71441: Current · expires 2028-04-30
Trained
New York Medical College, 1998
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A714410
Taxonomy
Federal specialty code 207RG0100X (207RG0100X); Federal specialty code 204F00000X (204F00000X); Internal medicine (207R00000X); Federal specialty code 207RI0008X (207RI0008X); Federal specialty code 207RT0003X (207RT0003X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2006-07-21
NPI last updated
2021-08-26
NPI record certified
2020-12-04

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 1601 Esplanade Ste 3, Chico, CA, 95926 · 2367 Harrison Ave, Eureka, CA, 95501 · 1189 E Herndon Ave, Fresno, CA, 93720 · 1401 Spanos Ct Ste 125, Modesto, CA, 95355 · 101 Rowland Way Ste 220, Novato, CA, 94945 · 3300 Webster St Ste 202, Oakland, CA, 94609 · 795 El Camino Real, Palo Alto, CA, 94301 · 1315 Alhambra Blvd Ste 210, Sacramento, CA, 95816 · 1431 Noriega St, San Francisco, CA, 94122 · 2340 Clay St Fl 2, San Francisco, CA, 94115 · 3880 S Bascom Ave Ste 113, San Jose, CA, 95124 · 3883 Airway Dr, Santa Rosa, CA, 95403 · 990 Sonoma Ave, Santa Rosa, CA, 95404